GSK-3β has been described as a negative regulator of cardiac hypertrophy induced by endothelin-1 [30], insulin-like growth factor 1 [31], β-adrenergic agonists, and pressure overload [15, 32]. This evidence concerns the gene IGF1 and cardiac hypertrophy.